Introduction
Securities fraud class actions are big business. More than fifty percent of federal class actions filed are securities class actions,
and over $114 billion has changed hands through securities class action settlements since 1996.
While the total number of filings has decreased significantly since 2017,
the magnitude of potential losses to be claimed continues to increase.
And there is little reason to believe this trend will slow down: Many have predicted that a recession is on the horizon,
and recessions are often correlated with fraud in financial markets.
By the numbers, legal standards in securities fraud litigation have a significant impact on corporations and the millions of Americans whose wealth is invested in the stock market.
And they may become even more salient in the coming years.
One of the most-argued elements in section 10(b) securities fraud class actions is the defendant’s scienter. Scienter refers to fraudulent intent; it is what separates fraud from negligent or accidental misstatements.
The concept of scienter is straightforward as applied to natural persons: What it means for an individual to intend or know something is clear, notwithstanding that intent and knowledge can be difficult to prove.
For corporate defendants, however, an additional layer of conceptual difficulty emerges. A corporation is a fictional person, by definition distinct from the natural persons who are its owners and take actions on its behalf.
This feature of the corporate form means that to determine whether a corporation has scienter, courts must first develop a theory of the corporate mind that accommodates this separation.
Even though corporations are regularly defendants in securities fraud class actions, and plaintiffs must plead scienter to establish claims against them,
organizational scienter remains “one of the greatly under-theorized subjects in all of securities litigation.”
This theoretical gap could be explained by the fact that imputation of intent through respondeat superior is deeply ingrained as a method for ascribing intent to corporations in the tort context.
But securities fraud is unlike other torts in its singular focus on deterrence
—specifically, this Note argues, optimal deterrence.
Respondeat superior liability is not suited to this goal.
Most circuits recognize the shortcomings of respondeat superior and deviate from it, sometimes without acknowledging the deviation.
Circuit court approaches to corporate scienter
can be sorted into three major groups: adherence to respondeat superior and variations,
collective scienter,
and the high managerial agent approach.
But analyzed under the framework of optimal deterrence, these alternative approaches each fall short.
This Note argues that courts should consider corporate institutional features in the definition of corporate scienter to better meet the ideal of optimal fraud deterrence. The concept of optimal deterrence is well adapted to the securities fraud context, where maintaining market efficiency is a primary goal.
Moreover, since optimal deterrence reflects a balancing of the arguments for and against private section 10(b) litigation against corporations, it is the key goal that should orient corporate scienter analysis. The optimal deterrence framework suggests that courts are right to move away from the pure application of respondeat superior, but they should consider adding a category of corporate scienter that looks to corporate structure and compliance efforts as proxies for organizational “intent” to defraud. The U.S. Sentencing Commission incorporates similar considerations in its Organizational Sentencing Guidelines,
and these guidelines provide helpful examples of corporate actions that could be factored in to the scienter analysis. Injecting these principles into the corporate scienter analysis in securities fraud cases will better calibrate corporations’ deterrence-related incentives. Corporate structure may determine who becomes aware of what information and when, and structures that prevent or inhibit the flow of information both prevent scienter from attaching to any corporate speaker and encourage fraud.
Consequently, structure and compliance measures reflect both the corporation’s intention and ability to prevent fraud, or not.
Part I summarizes the law of federal securities fraud class actions and explores the building blocks of corporate scienter. It also introduces the optimal deterrence goal that guides the remainder of the argument. Part II explains the ongoing circuit split and argues that each of the currently prevailing approaches is systematically either over- or underdeterrent. Part III proposes a new category of corporate scienter oriented to the idea of organizational fault. Inspired in part by the Organizational Sentencing Guidelines, this new category would allow courts to consider corporate structure and compliance alongside the traditional imputation analysis. Part III concludes by reviewing two hypothetical case studies that show how the proposed scienter concept is better equipped than predecessors to handle certain sets of facts that can arise in securities class actions.